MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Pre-Tax Margin

Income before tax as a percentage of revenue.

MindWalk Holdings Corp.NASDAQ: HYFT

Pre-Tax Margin · Q3 FY2026 · quarter ended Jan 2026

Pre-tax margin widens to -94.9%

Pre-tax margin was -94.9% in Q3 FY2026, up 303.9 pp from a year earlier. On a trailing-twelve-month basis it was -71.7%, up 224.0 pp year over year. Over 3 fiscal years it narrowed by 57.9 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
-94.9%-17.5 pp QoQ
Last fiscal yearApr 2025
-139.8%-22.7 pp YoY
LTMJan 2026
-71.7%+224.0 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+303.9 pp——
1 year-22.7 pp——
3 years-57.9 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-139.8%
Year-over-year change
-22.7pp

Pre-Tax Margin vs competitors

How HYFT compares with its peers on the latest reported figures

  • HYFT's LTM Jan 2026 pre-tax margin of -71.7% is the 2nd highest of the 5 companies compared; the peer median is -13601.7%.
  • Its year-over-year change of +224.0 pp is the 3rd highest of 4, against a peer median of +385.1 pp.
  • Over three fiscal years its change of -57.9 pp compares with a peer median of -6761.3 pp.
HYFT Competitors Peer median
Pre-Tax Margin for HYFT and competitors
Company Period LTM level YoY 3-year change
FBIOFortress Biotech, Inc.LTM Mar 2026201.4% +385.1 pp+228.8 pp
HYFTMindWalk Holdings Corp.LTM Jan 2026-71.7% +224.0 pp-57.9 pp
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026-2193.7% +1234.9 pp—
CLNNClene Inc.LTM Mar 2026-25009.7% -16703.7 pp-6761.3 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-36859.5% —-38572.9 pp
ALXOALX Oncology Holdings Inc.FY2025— ——
UNCYUnicycive Therapeutics, Inc.FY2025— ——
BYSIBeyondSpring Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding HYFT) -13601.7%+385.1 pp-6761.3 pp

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.